In line with its mission to herald regional thought leadership in the life sciences and biotechnology sector in Kuwait and the region, Kuwait Life Sciences is proud to announce the publication of a chapter by Dr. Mussaad M. Al-Razouki on "Growth Hacking Healthcare:Scaling Your Venture" in the book entitled: Digital Health Entrepreneurship by Springer, a globally active publisher dedicated to the advancement of science. For a preview of the chapter please click the following link.
The book presents a hands-on approach to the digital health innovation and entrepreneurship roadmap for digital health entrepreneurs and medical professionals who are dissatisfied with the existing literature on or are contemplating getting involved in digital health entrepreneurship. Topics covered include regulatory affairs featuring detailed guidance on the legal environment, protecting digital health intellectual property in software, hardware, and business processes, financing a digital health startup, cybersecurity best practice, and digital health business model testing for desirability, feasibility, and viability.
Digital Health Entrepreneurship is directed to clinicians and other digital health entrepreneurs and stresses an interdisciplinary approach to product development, deployment, dissemination, and implementation. It, therefore, provides an ideal resource for medical professionals across a broad range of disciplines seeking a greater understanding of digital health innovation and entrepreneurship.
For a preview of the book, please visit the following link.
This is the second time that Dr. Mussaad has been invited to contribute a chapter to a Springer publication on digital health. In early 2018, Dr. Razouki contributed a chapter on "Who Will Pay for Digital Health: The Investors Point of View" to the book entitled: Digital Health: Scaling Healthcare to the World addresses the emerging trends and enabling technologies contributing to technological advances in the future practice of healthcare in the 21st Century and beyond.
The book presented a comprehensive state-of-the-art approach to digital health technologies and practices within the broad confines of healthcare practices. It also provided a canvas to discuss emerging digital health solutions, propelled by the ubiquitous availability of miniaturized, personalized devices and affordable, easy to use wearable sensors, and innovative technologies like 3D printing, virtual and augmented reality and driverless robots and vehicles including drones. Indeed, one of the most significant promises the digital health solutions hold is to keep us healthier for longer, even with limited resources, while truly scaling the delivery of healthcare.
For a preview of the first book, please visit the following link.
Dr. Mussaad M. Al-Razouki (Chapter 20) is the only contributor from the Arab WorldAbout KLSC:Kuwait Life Sciences (KLSC) was established in 2010, with a paid up capital of 18 million Kuwait Dinars (KD) which is equivalent to approximately $60 million US Dollars. KLSC is fully owned by National Technology Enterprises Company. National Technology Enterprises Company (NTEC) was incorporated in November of 2002, by the Kuwait Council of Ministers as a fully owned company by the Kuwait Investment Authority (KIA), the sovereign wealth fund of the State of Kuwait. Capitalized at 100 million Kuwait Dinars (KD) which is equivalent to approximately $350 million US Dollars, NTEC aims to play a vital role in servicing major stakeholders in Kuwait and the Middle East region with their technology requirements.
KLSC focuses on healthcare innovative concepts and demanded services which have a clear and unmet need in the Middle East and North Africa (MENA) region. KLSC has been designed as an integrated healthcare company building unique projects and is considered one of the pioneer venture capitalist and private equity companies in the Middle East that invests globally and operates regionally seeking to advance healthcare services and systems within the region. KLSC supports both public and private sector stakeholders to access emerging technologies, establish unique projects and adopt best practices prevailing in today’s healthcare field. KLSC operates in healthcare investment, life sciences training, medical technology, and pharmaceutical distribution.
For Further Press Enquiries:
Email KLSC at: info@klsc.com.kw
Our mailing address is:
KIPCO Tower, 27th floor, Block 9
Al Shohadaa Street, Sharq
P.O.Box 25363, Safat 13114 Kuwait
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
